MedTrace Logo

Evaluation of Damaging Factors to Endothelial Glycocalyx During Heart Surgery Pilot Study

NCT03491163 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2018-08-07

No results posted yet for this study

Summary

Evaluation of endothelial glycocalyx damage in on-pump conventional coronary artery bypass surgery using a syndecan-1 (CD138) blood test. The study will be carried out in two stages. Pilot study for testing and correcting research methodology and the main study.

Conditions

  • Heart; Surgery, Heart, Functional Disturbance as Result

Interventions

DIAGNOSTIC_TEST

Syndecan-1 concentration evaluation

Blood sample will be taken and analysed using ELISA method.

Sponsors & Collaborators

  • Tadas Cesnaitis

    lead OTHER

Principal Investigators

  • Edmundas Sirvinskas, Prof · Professor at Lithuanian University of Health Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-29
Primary Completion
2019-10-30
Completion
2020-07-01

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491163 on ClinicalTrials.gov